NOVO Genomics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
NOVO Genomics General Information
Description
Provider of genomic and multi-omics laboratory services intended for clinical diagnostics and personalized healthcare. The company offers DNA sequencing, genetic screening for inherited conditions, pharmacogenomic testing, non-invasive prenatal testing, and research-based genomic studies, complemented by bioinformatics analysis, advanced analytics and data mining, and personalized data interpretation, enabling healthcare providers and patients across Saudi Arabia and the broader region to achieve accurate diagnoses, early detection of genetic conditions, and data-driven treatment decisions.
Contact Information
Website
www.novogenomics.saCorporate Office
- 7045 Prince Muhammad Ibn Saad Ibn Abdulaziz Road
- Al Malqa
- Riyadh 13524
- Saudi Arabia
Corporate Office
- 7045 Prince Muhammad Ibn Saad Ibn Abdulaziz Road
- Al Malqa
- Riyadh 13524
- Saudi Arabia
NOVO Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 19-Jun-2025 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Apr-2022 | Completed | Generating Revenue |
NOVO Genomics Comparisons
Industry
Financing
Details
NOVO Genomics Competitors (3)
One of NOVO Genomics’s 3 competitors is CeGaT, a Corporate Backed or Acquired company based in Tubingen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CeGaT | Corporate Backed or Acquired | Tubingen, Germany | ||||
| Centogene | Private Equity-Backed | Rostock, Germany | ||||
| Eurofin (Commercial Services) | Corporate Backed or Acquired | Treviso, Italy |
NOVO Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NOVO Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NOVO Genomics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Emkan Capital | Venture Capital | Minority |
NOVO Genomics FAQs
-
When was NOVO Genomics founded?
NOVO Genomics was founded in 2022.
-
Where is NOVO Genomics headquartered?
NOVO Genomics is headquartered in Riyadh, Saudi Arabia.
-
What is the size of NOVO Genomics?
NOVO Genomics has 17 total employees.
-
What industry is NOVO Genomics in?
NOVO Genomics’s primary industry is Drug Discovery.
-
Is NOVO Genomics a private or public company?
NOVO Genomics is a Private company.
-
What is NOVO Genomics’s current revenue?
The current revenue for NOVO Genomics is .
-
Who are NOVO Genomics’s investors?
Emkan Capital has invested in NOVO Genomics.
-
Who are NOVO Genomics’s competitors?
CeGaT, Centogene, and Eurofin (Commercial Services) are competitors of NOVO Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
